Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Roose

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Haematologica|December 1, 2022
Modern, real-world patterns of care and clinical outcomes among patients with newly diagnosed diffuse large B-cell lymphoma with or without double/triple-hit status in the United StatesGaurav Goyal, Tylan Magnusson, Xiaoliang Wang, et al.
Extreme Physiology & Medicine|September 28, 2013
Lessons from history: morbidity of cold injury in the Royal Marines during the Falklands Conflict of 1982Francis St Clair Golden, Thomas James Roose Francis, Deborah Gallimore, et al.
Plos One|May 11, 2023
RWD-derived response in multiple myelomaTao Xu, James Roose, Mellissa Williamson, et al.
Blood Cancer Journal|March 23, 2024
Once-weekly versus twice-weekly bortezomib in newly diagnosed multiple myeloma: a real-world analysisFieke W Hoff, Rahul Banerjee, Adeel M Khan, et al.
Epidemiologic Methods|September 29, 2025
Regression calibration for time-to-event outcomes: mitigating bias due to measurement error in real-world endpointsBenjamin Ackerman, Ryan W Gan, Youyi Zhang, et al.
Frontiers in Drug Safety and Regulation|September 22, 2025
Measurement error and bias in real-world oncology endpoints when constructing external control armsBenjamin Ackerman, Ryan W Gan, Craig S Meyer, et al.
American Journal of Epidemiology|February 6, 2026
Quantitative bias analyses to address measurement error in time-to-event endpointsBenjamin Ackerman, Ryan W Gan, Youyi Zhang, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Haematologica|December 1, 2022
Modern, real-world patterns of care and clinical outcomes among patients with newly diagnosed diffuse large B-cell lymphoma with or without double/triple-hit status in the United StatesGaurav Goyal, Tylan Magnusson, Xiaoliang Wang, et al.
Extreme Physiology & Medicine|September 28, 2013
Lessons from history: morbidity of cold injury in the Royal Marines during the Falklands Conflict of 1982Francis St Clair Golden, Thomas James Roose Francis, Deborah Gallimore, et al.
Plos One|May 11, 2023
RWD-derived response in multiple myelomaTao Xu, James Roose, Mellissa Williamson, et al.
Blood Cancer Journal|March 23, 2024
Once-weekly versus twice-weekly bortezomib in newly diagnosed multiple myeloma: a real-world analysisFieke W Hoff, Rahul Banerjee, Adeel M Khan, et al.
Epidemiologic Methods|September 29, 2025
Regression calibration for time-to-event outcomes: mitigating bias due to measurement error in real-world endpointsBenjamin Ackerman, Ryan W Gan, Youyi Zhang, et al.
Frontiers in Drug Safety and Regulation|September 22, 2025
Measurement error and bias in real-world oncology endpoints when constructing external control armsBenjamin Ackerman, Ryan W Gan, Craig S Meyer, et al.
American Journal of Epidemiology|February 6, 2026
Quantitative bias analyses to address measurement error in time-to-event endpointsBenjamin Ackerman, Ryan W Gan, Youyi Zhang, et al.
Pageof 1